Pharma's Almanac: Nice Insight's Content Community

ad image

Articles
Expert Interviews
Roundtable
Press Releases
Videos

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Alexion Pharmaceuticals, Inc.

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Our Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2025 PHARMA’S ALMANAC. All rights reserved.

1 / 1

1 / 1

Rumors Suggest Amgen is Interested in Alexion

Investment

Rumors Suggest Amgen is Interested in Alexion

Nice Insight

PAO-M00-19-NI-001Sep 04, 2019

Alexion Acquires Minority Stake in Caelum Biosciences

Acquistion

Alexion Acquires Minority Stake in Caelum Biosciences

David Alvaro, Ph.D.

Pharma's Almanac

PAO-M02-19-NI-007Feb 07, 2019

First Treatment for Generalized Myasthenia Gravis Approved After 60 Years

FDA Approval

First Treatment for Generalized Myasthenia Gravis Approved After 60 Years

Guy Tiene

Nice Insight

PAO-M10-17-NI-039Oct 26, 2017